Shuai Wu

4.5k total citations · 1 hit paper
78 papers, 3.4k citations indexed

About

Shuai Wu is a scholar working on Molecular Biology, Epidemiology and Surgery. According to data from OpenAlex, Shuai Wu has authored 78 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 15 papers in Epidemiology and 13 papers in Surgery. Recurrent topics in Shuai Wu's work include Gut microbiota and health (10 papers), Infant Nutrition and Health (9 papers) and MicroRNA in disease regulation (8 papers). Shuai Wu is often cited by papers focused on Gut microbiota and health (10 papers), Infant Nutrition and Health (9 papers) and MicroRNA in disease regulation (8 papers). Shuai Wu collaborates with scholars based in China, United States and United Kingdom. Shuai Wu's co-authors include Carlito B. Lebrilla, J. Bruce German, Zhaohua Shen, Xiaoyan Wang, Weiwei Luo, Bei Tan, Rudolf Grimm, Yongsheng Quan, Changxin Zhu and Zhenyu Yang and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Shuai Wu

72 papers receiving 3.4k citations

Hit Papers

Relationship between intestinal microbiota and ulcerative... 2018 2026 2020 2023 2018 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shuai Wu China 30 1.8k 1.1k 648 625 446 78 3.4k
Glauben Landskron Chile 10 2.6k 1.4× 423 0.4× 519 0.8× 366 0.6× 490 1.1× 17 4.5k
Eric L. Campbell United States 31 2.9k 1.6× 775 0.7× 678 1.0× 574 0.9× 344 0.8× 57 6.0k
Laura Stronati Italy 34 1.4k 0.8× 304 0.3× 582 0.9× 650 1.0× 264 0.6× 87 3.3k
Mingming Sun China 35 3.0k 1.7× 303 0.3× 639 1.0× 573 0.9× 412 0.9× 92 4.7k
Xia Xiao China 30 1.3k 0.7× 420 0.4× 306 0.5× 386 0.6× 170 0.4× 150 3.2k
Debby Laukens Belgium 33 1.6k 0.9× 275 0.3× 733 1.1× 611 1.0× 254 0.6× 93 3.3k
Sathish Sivaprakasam United States 19 2.5k 1.4× 322 0.3× 358 0.6× 303 0.5× 384 0.9× 38 3.6k
Mauro Rossi Italy 38 1.2k 0.6× 583 0.5× 645 1.0× 738 1.2× 412 0.9× 146 4.0k
Manfred Nairz Austria 40 1.2k 0.7× 1.4k 1.4× 193 0.3× 548 0.9× 168 0.4× 78 5.6k

Countries citing papers authored by Shuai Wu

Since Specialization
Citations

This map shows the geographic impact of Shuai Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuai Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuai Wu more than expected).

Fields of papers citing papers by Shuai Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuai Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuai Wu. The network helps show where Shuai Wu may publish in the future.

Co-authorship network of co-authors of Shuai Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Shuai Wu. A scholar is included among the top collaborators of Shuai Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuai Wu. Shuai Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
4.
Wu, Shuai, et al.. (2025). Amphotericin B delivery systems: Current advances and potential directions in oral candidiasis treatment. 2(1). 100021–100021. 1 indexed citations
5.
Qu, Kai, Yuan Zhong, Li Zhu, et al.. (2024). A Macrophage Membrane‐Functionalized, Reactive Oxygen Species‐Activatable Nanoprodrug to Alleviate Inflammation and Improve the Lipid Metabolism for Atherosclerosis Management. Advanced Healthcare Materials. 13(26). e2401113–e2401113. 10 indexed citations
6.
Zhao, Peng, Li Zhang, Yin Liu, et al.. (2023). Genetic diversity and phylogenetic relationship estimation of Shanxi indigenous goat breeds using microsatellite markers. Animal Biotechnology. 35(1). 2276717–2276717. 1 indexed citations
7.
Luo, Weiwei, Li Tian, Bei Tan, et al.. (2021). Update: Innate Lymphoid Cells in Inflammatory Bowel Disease. Digestive Diseases and Sciences. 67(1). 56–66. 41 indexed citations
8.
Zhang, Jin, Shuai Wu, Jialin Xu, et al.. (2020). Comparison of ashing and pyrolysis treatment on cadmium/zinc hyperaccumulator plant: Effects on bioavailability and metal speciation in solid residues and risk assessment. Environmental Pollution. 272. 116039–116039. 32 indexed citations
9.
Yan, Hui, María E. Fernández, Shuai Wu, et al.. (2020). B Cell Endosomal RAB7 Promotes TRAF6 K63 Polyubiquitination and NF-κB Activation for Antibody Class-Switching. The Journal of Immunology. 204(5). 1146–1157. 9 indexed citations
10.
Yan, Hui, Suryavathi Viswanadhapalli, María Fernández, et al.. (2020). Abstract P5-04-05: Tumor-infiltrating B lymphocytes produce IL-27 to upregulate PD-L1 expression in the tumor microenvironment and promote breast cancer progression. Cancer Research. 80(4_Supplement). P5–4. 1 indexed citations
11.
Gu, Siyu, Shuai Wu, Yupeng Guan, et al.. (2020). Arbuscular mycorrhizal fungal community was affected by tillage practices rather than residue management in black soil of northeast China. Soil and Tillage Research. 198. 104552–104552. 31 indexed citations
12.
Xiao, Mengwei, Zhaohua Shen, Weiwei Luo, et al.. (2019). A new colitis therapy strategyviathe target colonization of magnetic nanoparticle-internalizedRoseburia intestinalis. Biomaterials Science. 7(10). 4174–4185. 17 indexed citations
13.
Luo, Weiwei, Zhaohua Shen, Minzi Deng, et al.. (2019). Roseburia�intestinalis supernatant ameliorates colitis induced in mice by regulating the immune response. Molecular Medicine Reports. 20(2). 1007–1016. 47 indexed citations
14.
Tan, Bei, Weiwei Luo, Zhaohua Shen, et al.. (2019). Roseburia intestinalis inhibits oncostatin M and maintains tight junction integrity in a murine model of acute experimental colitis. Scandinavian Journal of Gastroenterology. 54(4). 432–440. 33 indexed citations
15.
Zhu, Changxin, Zhaohua Shen, Yongsheng Quan, et al.. (2018). Roseburia intestinalis inhibits interleukin‑17 excretion and promotes regulatory T cells differentiation in colitis. Molecular Medicine Reports. 17(6). 7567–7574. 118 indexed citations
16.
Quan, Yongsheng, Yan Zhang, Changxin Zhu, et al.. (2018). Roseburia intestinalis -derived flagellin is a negative regulator of intestinal inflammation. Biochemical and Biophysical Research Communications. 501(3). 791–799. 59 indexed citations
18.
Leoz, Maria Lorna A. De, Shuai Wu, John S. Strum, et al.. (2013). A quantitative and comprehensive method to analyze human milk oligosaccharide structures in the urine and feces of infants. Analytical and Bioanalytical Chemistry. 405(12). 4089–4105. 82 indexed citations
19.
Wu, Shuai. (2013). Intranasal Delivery of Neural Stem Cells: A CNS-specific, Non-invasive Cell-based Therapy for Experimental Autoimmune Encephalomyelitis. Journal of Clinical & Cellular Immunology. 4(3). 37 indexed citations
20.
Wu, Shuai, Rudolf Grimm, J. Bruce German, & Carlito B. Lebrilla. (2010). Annotation and Structural Analysis of Sialylated Human Milk Oligosaccharides. Journal of Proteome Research. 10(2). 856–868. 211 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026